Research Article
Mechanism of Cordyceps Cicadae in Treating Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking Analysis
Table 1
Candidate compounds of cordyceps cicadae.
| No. | Name of compounds | Number of targets | No. | Name of compounds | Number of targets |
| C1 | Oleic acid | 24 | C32 | Cerevisterol | 0 | C2 | EIC | 15 | C33 | Cholesteryl palmitate | 0 | C3 | Arachidonic acid | 38 | C34 | (2R,3S,5S)-5-(6-Aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol | 3 | C4 | Linoleyl acetate | 4 | C35 | (2R,3R,4S)-2-(6-Aminopurin-9-yl)-4-(hydroxymethyl)oxolan-3-ol | 3 | C5 | Vitamin C | 6 | C36 | Cordylagenin | 1 | C6 | Uracil | 13 | C37 | CLR | 4 | C7 | Adenine | 4 | C38 | Cinnamaldehyde | 12 | C8 | Styrone | 0 | C39 | Ignavine | 0 | C9 | 20-Hexadecanoylingenol | 0 | C40 | Deoxyandrographolide | 3 | C10 | Vitamin G | 2 | C41 | Karakoline | 0 | C11 | D-Mannoheptulose | 0 | C42 | Isotalatizidine | 0 | C12 | Ergosterol | 5 | C43 | Neokadsuranic acid A | 0 | C13 | MTL | 2 | C44 | 2,7-Dideacetyl-2,7-dibenzoyl-taxayunnanine F | 0 | C14 | Beta-sitosterol | 38 | C45 | 3-Acetylaconitine | 0 | C15 | Caffeine | 54 | C46 | Berberine | 12 | C16 | TGL | 0 | C47 | Neokadsuranic acid C | 1 | C17 | Nicotinic acid | 17 | C48 | Hypaconitine | 0 | C18 | GLB | 34 | C49 | Deoxyaconitine | 0 | C19 | Uralene | 15 | C50 | Adenosine | 0 | C20 | TRE | 0 | C51 | N-(2-Hydroxyethyl)adenosine | 0 | C21 | GUP | 23 | C52 | 1-[(2R,3R,4S,5S)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione | 0 | C22 | Uridine | 2 | C53 | Inosine | 89 | C23 | Thiamine | 4 | C54 | Guanosine | 107 | C24 | Peroxyergosterol | 0 | C55 | GUN | 1 | C25 | Galactomannan | 1 | C56 | Beauverin | 0 | C26 | Palmitic acid | 17 | C57 | N-(4-Aminobenzoyl)-L-glutamic acid | 0 | C27 | Linoleic | 14 | C58 | Myriocin | 89 | C28 | NCA | 7 | C59 | Ergosta-4,6,8(14),22-tetraene-3-one | 1 | C29 | Stearic acid | 7 | C60 | Hyaluronic acid | 0 | C30 | LFA | 0 | C61 | 5,6-Epoxyergosta-7,22-dien-3-ol | 0 | C31 | Isoergotamine | 0 | | | |
|
|